Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

BYSI BeyondSpring Inc

1,70

0,04 (2,41%)

Zuletzt aktualisiert: 19:25:37

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

BeyondSpring (NASDAQ:BYSI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more BeyondSpring Charts.

BeyondSpring (NASDAQ:BYSI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more BeyondSpring Charts.

News BeyondSpring Inc

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 31 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting
Montag 11 November 2024 (2 Monate vor) • GlobeNewswire Inc.

BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024
Montag 16 September 2024 (4 Monate vor) • GlobeNewswire Inc.

BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory Medici
Dienstag 10 September 2024 (4 Monate vor) • GlobeNewswire Inc.

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin
Dienstag 3 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 29 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 6 August 2024 (5 Monate vor) • Edgar (US Regulatory)

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
Dienstag 6 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form F-3 - Registration statement by foreign private issuers
Mittwoch 12 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 12 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 12 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Weitere BeyondSpring Inc News-Artikel

Deutsche Telekom

Invesco QQQ Trust Series 1

Euro vs Sterling

Deutsche Telekom (QX)

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen